Working with CCBR speeds up and drives efficiencies in clinical trials. CCBR recruits significant numbers of patients through our network of dedicated Clinical Research Centres, in greater numbers than can be achieved through using ‘non CCBR investigator sites’, which in turn offers significant and recognisable cost & time savings across clinical studies and programs, as well as offering cost savings associated with sponsor’s internal costs for conducting trials. CCBR has a proven heritage and history of delivering high quality study data and high patient numbers after working across many different therapy areas, completing recruitment in over 350 Phase II-IV studies, randomising over 40,000 patients.
Analysis and research into clinical studies has shown that many Pharma are still operating on an outdate ‘development roadmap’, spending on average $18m across each and every clinical development program opening sites that do not recruit a single patient and facing regular costly development issues that extend development timelines and cost a great deal of money.
CCBR offers a new roadmap to clinical development success, speeding up and driving recognisable efficiencies in clinical trials.
CCBR recruits significant numbers of patients through our network of dedicated Clinical Research Centres, in greater numbers than can be achieved through using ‘non CCBR investigator sites’, which in turn offers significant and recognisable cost & time savings across clinical studies and programs, as well as offering cost savings associated with sponsor’s internal costs for conducting trials.
CCBR has a proven heritage and history of delivering high quality study data and high patient numbers after working across many different therapy areas, completing recruitment in over 350 Phase II-IV studies, randomising over 40,000 patients.
A Global Footprint covering 16 dedicated Clinical Research Centres, spanning 10 countries including, Denmark, Poland, Czech Republic, Romania, Estonia, Lithuania, China, Hong Kong, Brazil, Argentina and Peru.
Teams of highly trained and experienced clinical staff focus only on clinical research and conducting clinical trials, all of their time.
CCBR offers a very different environment for conducting clinical trials when compared to ‘non CCBR investigator sites’, where staff undertake other work and have many distractions to take focus away from offering high quality data and fully committing to the success of a clinical study.
Global & Standardised SOPs operate across every CCBR Clinical Research Centre and all staff, with each site & clinical staff using CCBR’s proprietary Booking System to drive high quality data and efficiencies into clinical studies.
Working with CCBR speeds up and drives efficiencies in clinical trials by offering greater numbers of patients across fewer sites
A Global Footprint covering 16 dedicated Clinical Research Centers in high density population areas
Uniform SOPs enable the tightest possible adherence to study protocols and consistency across all CCBR sites
Real-Time tacking of subject enrolment and trial progress ensures sponsors have the most up to date information, all of the time
Centralised, standardised billing affords better visibility into trial costs for sponsors
